ABSTRACT
Introduction
Glucocorticoids play an important role in the control of feeding behavior.
Increased food intake and body weight gain are associated with glucocorticoid treatment in humans (46) . On the other hand, bilateral adrenalectomy (ADX) reduces food intake and body weight gain, and these effects are reversed by glucocorticoid replacement in rats (12) . Furthermore, ADX reduces hyperphagia and obesity in different experimental models, whereas glucocorticoid replacement reverses these effects (4, 8, 52). Hypophagia induced by ADX has been associated with a decrease of hypothalamic neuropeptide Y (NPY) mRNA expression, a potent orexigenic neuropeptide (41) . Adrenalectomy may also reduce food intake through the increase of corticotrophin-releasing factor (CRF) mRNA expression in the paraventricular nucleus (PVN), since CRF is a well known anorexigenic peptide (1, 2) . CRF neurons in the PVN receive projections from neurons of the nucleus of the solitary tract (NTS) (6, 35, 45) . This brainstem nucleus receives sensory information from gastrointestinal tract and abdominal viscera, as well as taste information from the oral cavity (19, 48) , being involved in the satiety pathways.
Satiety signals control meal size and include mechanical and chemical stimulation of stomach and small intestine, as well as hormones released during feeding (16, 38) . Oral, pharyngeal and esophageal stimulation and gastric distension induce Fos expression in catecholamine expressing neurons in the NTS (11, 51).
Furthermore, duodenal nutrient infusion inhibits food intake and induces neuron activation in the NTS (29) , with a positive correlation between the amount of food intake and this neuron activation (54) .
Responses associated with satiety also involve hypothalamic pathways, such as PVN and arcuate nucleus (ARC), as demonstrated by their activation following 4 food intake (39) . These nuclei have been implicated in the control of energy homeostasis and express orexigenic and anorexigenic peptides (38) . PVN receives projections not only from satiety-related neurons of the NTS, but also from ARC neurons (38) , indicating that hypothalamus plays an important role in the integrative responses that control food intake.
Several hormones released during a meal, such as cholecystokinin (CCK), glucagon-like peptide 1 (GLP-1) and bombesin (26) are known to participate in the satiety associated responses (16) . CCK is a meal-related signal released from mucosal endocrine cells in response to nutrients entering the duodenum (13, 27) . CCK induces pyloric and gallbladder contraction and inhibits gastric emptying (20, 25) . It also inhibits food intake in rodents and humans (14, 18) , through an activation of NTS neurons mediated by vagal afferent fibers (10, 22). Furthermore, catecholaminergic neurons in the NTS have been shown to be activated by CCK treatment (31, 37) .
To investigate the role of glucocorticoids on satiety associated responses, the present study was designed to evaluate the effects of adrenalectomy and glucocorticoid replacement on activation of NTS catecholaminergic neurons, CRF neurons in the PVN and ARC neurons induced by feeding. We also investigated the food intake and the activation of NTS neurons in response to CCK stimulation.
EXPERIMENTAL PROCEDURES

Animals
Male Wistar rats (200-250 g) obtained from the Animal Facility of the Campus of Ribeirao Preto, University of Sao Paulo, Brazil were housed in individual cages, in controlled conditions of temperature (23± 2ºC) and a fixed light-dark cycle (lights from 6:00 AM to 6:00 PM). Animals had ad libitum access to pelleted rat chow and fluid, unless otherwise specified. To improve adaptation to the laboratory, rats were handled daily during 7 days before experiments. All experimental procedures were conducted between 7:00 AM-12:00 PM and were approved by the Ethical Committee for Animal Use of the School of Medicine of Ribeirao Preto, University of Sao Paulo.
Bilateral adrenalectomy and sham surgery were performed under 2.5% 2,2,2-tribromoethanol (1 ml/100g of body weight, i.p.) anesthesia via dorsal incision. Sham operated animals underwent similar surgical procedures without removal of the adrenal glands. All ADX animals were given 0.9% saline to drink during the experimental period, and half of them were also supplemented with 25 mg/l corticosterone (B) in 0.5% ethanol dissolved in 0.9% saline. To ensure completeness of ADX surgery and the adequacy of glucocorticoid replacement, B plasma levels were determined by radioimmunoassay (5). ADX animals with 0.9% saline showed undetectable B plasma levels. Plasma corticosterone levels were measured seven days after surgery in ad libitum food intake (Experiment 1) and also after 16 hours of fasting (Experiment 2).
Perfusion, tissue preparation and immunohistochemistry
Animals were anesthetized with i.p. injection of 2.5% tribromoethanol (1 ml/100g of body weight, i.p.). Thereafter, rats were transcardially perfused with 200 ml of cold isotonic saline containing heparin (50UI/l), followed by 500 ml of cold 4% paraformaldehyde solution in 0.1M phosphate buffer (PB), pH 7. Rats were housed in metabolic cages, and were subjected to sham or ADX surgery. Half of ADX animals were replaced with B (ADX+B) in their drinking water (25 mg/l B in 0.9% NaCl with 0.5% ethanol). During 7 days following surgery, food intake, body weight and fluid intake were monitored daily in the morning.
Experiment 2: Effects of ADX and B replacement on food intake and neuron activation in the NTS, PVN, ARC and RCA in the fasting-refeeding regimen.
Animals were divided into sham, ADX or ADX+B groups and kept in metabolic cages. Six days after surgery, they were fasted from 4:00 PM until 8:00 AM the next day (16 hours of fasting) and fluid intake of this period of fasting was 8 measured. Food was reintroduced and food intake was determined after 2 hours of refeeding. Another set of sham, ADX and ADX+B rats, kept in individual cages, was fasted for 16 hours, as described above on the 6 th day after surgery, and thereafter they were transcardiacally perfused, before or 2 hours after refeeding, for brain tissue collection and immunohistochemistry studies.
Experiment 3: Effects of ADX and corticosterone replacement on food intake and catecholaminergic neuron activation in the NTS after CCK administration.
Animals were divided into sham, ADX or ADX+B and kept in individual cages. Six days after surgery, animals were fasted for 16 hours, as described above, and on 7 th day after surgery they were injected with CCK (Bachem, 3.5 μg/kg i.p.) or vehicle (0.9% NaCl). Soon after the injections, all animals had access to food, and food intake was determined during 2 hours. Another set of sham, ADX and ADX+B rats, fasted for 16 hours, was subjected to the same treatment with CCK or vehicle, and 2 hours after they were transcardiacally perfused, for brainstem tissue collection and immunohistochemistry studies.
Statistical analysis
Data were expressed as means ± SEM. Kruskal-Wallis test (experiments 1 and 2), followed by Dunn´s post-test, and two-way ANOVA, followed by Bonferroni post-test (experiments 2 and 3), were used when appropriate. Differences were considered significant at P<0.05.
RESULTS
Experiment 1: Effects of ADX and B replacement on food intake, body weight gain and fluid intake.
Adrenalectomized group showed reduced (P<0.001) mean daily food intake 
DISCUSSION
The present study investigated the effects of adrenalectomy and glucocorticoid replacement on activation of NTS, PVN, RCA and ARC neurons induced by feeding.
We observed that ADX reduced food intake and body weight gain, with an increased activation of NTS, PVN, RCA and ARC neurons after refeeding.
To investigate the effect of glucocorticoid withdrawal, we used adrenalectomized rats with and without corticosterone replacement in drinking fluid.
Jacobson et al (17) using corticosterone pellet in adrenalectomized rats showed constant corticosterone plasma levels, whereas replacement in the drinking water It is well established that glucocorticoid deficiency causes hypophagia, however there is no report on the effects of ADX in the satiety. The present study is the first to demonstrate that in the absence of glucocorticoid, the responses associated with satiety are augmented, as shown by the increased Fos and Fos/TH expression within the NTS after refeeding in ADX animals. NTS is known as the site which relays satiety signals and it is implicated in the short-term control of food intake (16).
Interestingly, glucocorticoid withdrawal induced a further activation of catecholaminergic and non-catecholaminergic neurons of the NTS after refeeding.
Glucocorticoid receptors were identified in the NTS catecholaminergic neurons (15, 24) , reinforcing that glucocorticoids can modulate neuron activation in the NTS during the short-term control of food intake. In humans, patients with chronic adrenal insufficiency present anorexia, weight loss, general malaise and nausea. Nausea itself could affect satiety; thus in adrenenalectomized rats, though difficult to be determined, it is conceivable that nausea could also contribute to the higher responses associated with satiety.
We observed that CCK reduced food intake in sham and ADX+B groups, confirming the anorexigenic effect of this peptide, as first described by Gibbs et al (14) . and may account to the lower food intake in ADX rats.
In summary, our results show that glucocorticoid withdrawal reduces food intake, which is associated with a higher activation of NTS, PVN, RCA and ARC neurons in response to feeding. Taken together, these data suggest that in the absence of glucocorticoids, meal-related signals elicited during feeding lead to an augmented activation of satiety associated responses through brainstem and hypothalamic pathways, which could contribute to the hypophagia in ADX animals. 
